nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—INSR—type 2 diabetes mellitus	0.234	0.528	CbGaD
Sunitinib—PRKAA1—type 2 diabetes mellitus	0.158	0.357	CbGaD
Sunitinib—ABCC2—type 2 diabetes mellitus	0.0355	0.08	CbGaD
Sunitinib—ABCC4—Nateglinide—type 2 diabetes mellitus	0.0258	0.166	CbGbCtD
Sunitinib—CYP3A4—type 2 diabetes mellitus	0.0157	0.0354	CbGaD
Sunitinib—ABCC2—Glyburide—type 2 diabetes mellitus	0.0104	0.0666	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0103	0.0658	CbGbCtD
Sunitinib—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0103	0.0658	CbGbCtD
Sunitinib—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0103	0.0658	CbGbCtD
Sunitinib—ABCG2—Glyburide—type 2 diabetes mellitus	0.00938	0.0602	CbGbCtD
Sunitinib—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00914	0.0586	CbGbCtD
Sunitinib—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0077	0.0494	CbGbCtD
Sunitinib—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00661	0.0424	CbGbCtD
Sunitinib—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00615	0.0394	CbGbCtD
Sunitinib—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00548	0.0351	CbGbCtD
Sunitinib—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00501	0.0321	CbGbCtD
Sunitinib—CYP3A5—Losartan—type 2 diabetes mellitus	0.00476	0.0305	CbGbCtD
Sunitinib—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00454	0.0291	CbGbCtD
Sunitinib—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00438	0.0281	CbGbCtD
Sunitinib—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00396	0.0254	CbGbCtD
Sunitinib—ABCB1—Glyburide—type 2 diabetes mellitus	0.00338	0.0217	CbGbCtD
Sunitinib—ABCB1—Losartan—type 2 diabetes mellitus	0.00309	0.0198	CbGbCtD
Sunitinib—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.003	0.0192	CbGbCtD
Sunitinib—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00288	0.0185	CbGbCtD
Sunitinib—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00288	0.0185	CbGbCtD
Sunitinib—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00272	0.0174	CbGbCtD
Sunitinib—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00203	0.013	CbGbCtD
Sunitinib—CYP3A4—Losartan—type 2 diabetes mellitus	0.00185	0.0119	CbGbCtD
Sunitinib—PIP4K2B—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00124	1	CbGdCrCtD
Sunitinib—Procainamide—DNMT1—type 2 diabetes mellitus	0.000971	1	CrCbGaD
Sunitinib—PRKAA1—cardiovascular system—type 2 diabetes mellitus	0.000163	0.00164	CbGeAlD
Sunitinib—TAOK3—islet of Langerhans—type 2 diabetes mellitus	0.000163	0.00164	CbGeAlD
Sunitinib—CAMK2G—pancreas—type 2 diabetes mellitus	0.000162	0.00163	CbGeAlD
Sunitinib—CLK1—cortex of kidney—type 2 diabetes mellitus	0.000162	0.00163	CbGeAlD
Sunitinib—IRAK1—nephron tubule—type 2 diabetes mellitus	0.000162	0.00163	CbGeAlD
Sunitinib—LRRK2—kidney—type 2 diabetes mellitus	0.000162	0.00163	CbGeAlD
Sunitinib—SGK3—liver—type 2 diabetes mellitus	0.000161	0.00163	CbGeAlD
Sunitinib—MERTK—adipose tissue—type 2 diabetes mellitus	0.000161	0.00162	CbGeAlD
Sunitinib—PTK2B—cardiovascular system—type 2 diabetes mellitus	0.000161	0.00162	CbGeAlD
Sunitinib—FLT4—cardiovascular system—type 2 diabetes mellitus	0.00016	0.00162	CbGeAlD
Sunitinib—ICK—liver—type 2 diabetes mellitus	0.00016	0.00161	CbGeAlD
Sunitinib—PRKAA1—kidney—type 2 diabetes mellitus	0.000159	0.0016	CbGeAlD
Sunitinib—CAMK2G—cortex of kidney—type 2 diabetes mellitus	0.000159	0.0016	CbGeAlD
Sunitinib—PRKAA1—pancreas—type 2 diabetes mellitus	0.000158	0.00159	CbGeAlD
Sunitinib—MAP4K4—adipose tissue—type 2 diabetes mellitus	0.000158	0.00159	CbGeAlD
Sunitinib—PTK2B—kidney—type 2 diabetes mellitus	0.000157	0.00159	CbGeAlD
Sunitinib—LRRK2—cortex of kidney—type 2 diabetes mellitus	0.000157	0.00159	CbGeAlD
Sunitinib—NUAK2—adipose tissue—type 2 diabetes mellitus	0.000157	0.00158	CbGeAlD
Sunitinib—MAP3K12—adipose tissue—type 2 diabetes mellitus	0.000156	0.00157	CbGeAlD
Sunitinib—NUAK1—liver—type 2 diabetes mellitus	0.000154	0.00156	CbGeAlD
Sunitinib—CSNK1E—pancreas—type 2 diabetes mellitus	0.000154	0.00155	CbGeAlD
Sunitinib—RPS6KA3—adipose tissue—type 2 diabetes mellitus	0.000154	0.00155	CbGeAlD
Sunitinib—SNRK—liver—type 2 diabetes mellitus	0.000153	0.00154	CbGeAlD
Sunitinib—INSR—liver—type 2 diabetes mellitus	0.000153	0.00154	CbGeAlD
Sunitinib—OXSR1—liver—type 2 diabetes mellitus	0.000153	0.00154	CbGeAlD
Sunitinib—FLT4—cortex of kidney—type 2 diabetes mellitus	0.000153	0.00154	CbGeAlD
Sunitinib—MAP2K1—adipose tissue—type 2 diabetes mellitus	0.000153	0.00154	CbGeAlD
Sunitinib—MAP2K2—cardiovascular system—type 2 diabetes mellitus	0.000152	0.00154	CbGeAlD
Sunitinib—SLK—nephron tubule—type 2 diabetes mellitus	0.000151	0.00152	CbGeAlD
Sunitinib—CSNK1E—cortex of kidney—type 2 diabetes mellitus	0.000151	0.00152	CbGeAlD
Sunitinib—FGFR1—cortex of kidney—type 2 diabetes mellitus	0.000151	0.00152	CbGeAlD
Sunitinib—RPS6KA2—liver—type 2 diabetes mellitus	0.000151	0.00152	CbGeAlD
Sunitinib—STK38—liver—type 2 diabetes mellitus	0.000151	0.00152	CbGeAlD
Sunitinib—CSNK1A1—adipose tissue—type 2 diabetes mellitus	0.000151	0.00152	CbGeAlD
Sunitinib—CLK1—adipose tissue—type 2 diabetes mellitus	0.00015	0.00151	CbGeAlD
Sunitinib—MAP2K2—kidney—type 2 diabetes mellitus	0.000149	0.0015	CbGeAlD
Sunitinib—PKN1—liver—type 2 diabetes mellitus	0.000148	0.0015	CbGeAlD
Sunitinib—CSNK1G2—liver—type 2 diabetes mellitus	0.000148	0.0015	CbGeAlD
Sunitinib—TBK1—cardiovascular system—type 2 diabetes mellitus	0.000148	0.00149	CbGeAlD
Sunitinib—MAP2K2—pancreas—type 2 diabetes mellitus	0.000148	0.00149	CbGeAlD
Sunitinib—FLT1—retina—type 2 diabetes mellitus	0.000147	0.00149	CbGeAlD
Sunitinib—TYK2—cardiovascular system—type 2 diabetes mellitus	0.000147	0.00148	CbGeAlD
Sunitinib—FYN—nephron tubule—type 2 diabetes mellitus	0.000147	0.00148	CbGeAlD
Sunitinib—CAMK2G—adipose tissue—type 2 diabetes mellitus	0.000147	0.00148	CbGeAlD
Sunitinib—BMP2K—adipose tissue—type 2 diabetes mellitus	0.000147	0.00148	CbGeAlD
Sunitinib—PRPF4—liver—type 2 diabetes mellitus	0.000146	0.00147	CbGeAlD
Sunitinib—LRRK2—adipose tissue—type 2 diabetes mellitus	0.000146	0.00147	CbGeAlD
Sunitinib—ULK3—cortex of kidney—type 2 diabetes mellitus	0.000145	0.00146	CbGeAlD
Sunitinib—MAP2K2—cortex of kidney—type 2 diabetes mellitus	0.000145	0.00146	CbGeAlD
Sunitinib—TBK1—kidney—type 2 diabetes mellitus	0.000145	0.00146	CbGeAlD
Sunitinib—PRPF4B—liver—type 2 diabetes mellitus	0.000144	0.00145	CbGeAlD
Sunitinib—TBK1—pancreas—type 2 diabetes mellitus	0.000144	0.00145	CbGeAlD
Sunitinib—TYK2—kidney—type 2 diabetes mellitus	0.000144	0.00145	CbGeAlD
Sunitinib—MAP3K3—nephron tubule—type 2 diabetes mellitus	0.000144	0.00145	CbGeAlD
Sunitinib—PRKAA1—adipose tissue—type 2 diabetes mellitus	0.000144	0.00145	CbGeAlD
Sunitinib—TYK2—pancreas—type 2 diabetes mellitus	0.000143	0.00144	CbGeAlD
Sunitinib—MAP3K7—cortex of kidney—type 2 diabetes mellitus	0.000143	0.00144	CbGeAlD
Sunitinib—RPS6KB1—cardiovascular system—type 2 diabetes mellitus	0.000143	0.00144	CbGeAlD
Sunitinib—PTK2B—adipose tissue—type 2 diabetes mellitus	0.000142	0.00143	CbGeAlD
Sunitinib—FGR—cardiovascular system—type 2 diabetes mellitus	0.000142	0.00143	CbGeAlD
Sunitinib—FLT4—adipose tissue—type 2 diabetes mellitus	0.000142	0.00143	CbGeAlD
Sunitinib—TBK1—cortex of kidney—type 2 diabetes mellitus	0.000141	0.00142	CbGeAlD
Sunitinib—IRAK1—pancreas—type 2 diabetes mellitus	0.000141	0.00142	CbGeAlD
Sunitinib—AXL—cardiovascular system—type 2 diabetes mellitus	0.000141	0.00142	CbGeAlD
Sunitinib—YES1—retina—type 2 diabetes mellitus	0.000141	0.00142	CbGeAlD
Sunitinib—CSNK2A1—liver—type 2 diabetes mellitus	0.00014	0.00141	CbGeAlD
Sunitinib—TYK2—cortex of kidney—type 2 diabetes mellitus	0.00014	0.00141	CbGeAlD
Sunitinib—FGFR1—adipose tissue—type 2 diabetes mellitus	0.00014	0.00141	CbGeAlD
Sunitinib—CSNK1E—adipose tissue—type 2 diabetes mellitus	0.00014	0.00141	CbGeAlD
Sunitinib—RPS6KB1—kidney—type 2 diabetes mellitus	0.000139	0.00141	CbGeAlD
Sunitinib—TAOK3—retina—type 2 diabetes mellitus	0.000139	0.0014	CbGeAlD
Sunitinib—FLT1—nephron tubule—type 2 diabetes mellitus	0.000139	0.0014	CbGeAlD
Sunitinib—RET—kidney—type 2 diabetes mellitus	0.000139	0.0014	CbGeAlD
Sunitinib—RPS6KB1—pancreas—type 2 diabetes mellitus	0.000139	0.0014	CbGeAlD
Sunitinib—MYLK—liver—type 2 diabetes mellitus	0.000139	0.0014	CbGeAlD
Sunitinib—IRAK1—cortex of kidney—type 2 diabetes mellitus	0.000138	0.0014	CbGeAlD
Sunitinib—IRAK4—adipose tissue—type 2 diabetes mellitus	0.000137	0.00139	CbGeAlD
Sunitinib—STK4—liver—type 2 diabetes mellitus	0.000136	0.00137	CbGeAlD
Sunitinib—RPS6KB1—cortex of kidney—type 2 diabetes mellitus	0.000136	0.00137	CbGeAlD
Sunitinib—FGFR2—cardiovascular system—type 2 diabetes mellitus	0.000135	0.00136	CbGeAlD
Sunitinib—AXL—cortex of kidney—type 2 diabetes mellitus	0.000134	0.00136	CbGeAlD
Sunitinib—ULK3—adipose tissue—type 2 diabetes mellitus	0.000134	0.00135	CbGeAlD
Sunitinib—MAP2K2—adipose tissue—type 2 diabetes mellitus	0.000134	0.00135	CbGeAlD
Sunitinib—JAK2—cardiovascular system—type 2 diabetes mellitus	0.000134	0.00135	CbGeAlD
Sunitinib—PHKG2—liver—type 2 diabetes mellitus	0.000134	0.00135	CbGeAlD
Sunitinib—MAP3K2—adipose tissue—type 2 diabetes mellitus	0.000133	0.00134	CbGeAlD
Sunitinib—STK24—liver—type 2 diabetes mellitus	0.000133	0.00134	CbGeAlD
Sunitinib—YES1—nephron tubule—type 2 diabetes mellitus	0.000133	0.00134	CbGeAlD
Sunitinib—MAP3K7—adipose tissue—type 2 diabetes mellitus	0.000132	0.00133	CbGeAlD
Sunitinib—FYN—cardiovascular system—type 2 diabetes mellitus	0.000132	0.00133	CbGeAlD
Sunitinib—SLK—pancreas—type 2 diabetes mellitus	0.000132	0.00133	CbGeAlD
Sunitinib—FGFR2—kidney—type 2 diabetes mellitus	0.000132	0.00133	CbGeAlD
Sunitinib—JAK2—kidney—type 2 diabetes mellitus	0.000131	0.00132	CbGeAlD
Sunitinib—TAOK3—nephron tubule—type 2 diabetes mellitus	0.000131	0.00132	CbGeAlD
Sunitinib—TBK1—adipose tissue—type 2 diabetes mellitus	0.000131	0.00132	CbGeAlD
Sunitinib—TYK2—adipose tissue—type 2 diabetes mellitus	0.00013	0.00131	CbGeAlD
Sunitinib—SLK—cortex of kidney—type 2 diabetes mellitus	0.000129	0.0013	CbGeAlD
Sunitinib—FYN—kidney—type 2 diabetes mellitus	0.000129	0.0013	CbGeAlD
Sunitinib—STK16—liver—type 2 diabetes mellitus	0.000129	0.0013	CbGeAlD
Sunitinib—MAP3K3—cardiovascular system—type 2 diabetes mellitus	0.000129	0.0013	CbGeAlD
Sunitinib—HIPK2—liver—type 2 diabetes mellitus	0.000128	0.0013	CbGeAlD
Sunitinib—HIPK3—liver—type 2 diabetes mellitus	0.000128	0.0013	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000128	0.00129	CbGeAlD
Sunitinib—IRAK1—adipose tissue—type 2 diabetes mellitus	0.000128	0.00129	CbGeAlD
Sunitinib—JAK2—cortex of kidney—type 2 diabetes mellitus	0.000128	0.00129	CbGeAlD
Sunitinib—TNK1—liver—type 2 diabetes mellitus	0.000127	0.00128	CbGeAlD
Sunitinib—RIOK2—liver—type 2 diabetes mellitus	0.000127	0.00128	CbGeAlD
Sunitinib—PDGFRB—islet of Langerhans—type 2 diabetes mellitus	0.000126	0.00127	CbGeAlD
Sunitinib—FYN—cortex of kidney—type 2 diabetes mellitus	0.000126	0.00127	CbGeAlD
Sunitinib—RPS6KB1—adipose tissue—type 2 diabetes mellitus	0.000126	0.00127	CbGeAlD
Sunitinib—MAP4K5—pancreas—type 2 diabetes mellitus	0.000125	0.00126	CbGeAlD
Sunitinib—FGR—adipose tissue—type 2 diabetes mellitus	0.000125	0.00126	CbGeAlD
Sunitinib—FLT1—cardiovascular system—type 2 diabetes mellitus	0.000125	0.00126	CbGeAlD
Sunitinib—KDR—retina—type 2 diabetes mellitus	0.000125	0.00126	CbGeAlD
Sunitinib—AXL—adipose tissue—type 2 diabetes mellitus	0.000124	0.00125	CbGeAlD
Sunitinib—DAPK3—liver—type 2 diabetes mellitus	0.000123	0.00124	CbGeAlD
Sunitinib—MAP4K5—cortex of kidney—type 2 diabetes mellitus	0.000123	0.00124	CbGeAlD
Sunitinib—MAP3K3—cortex of kidney—type 2 diabetes mellitus	0.000123	0.00124	CbGeAlD
Sunitinib—CLK2—liver—type 2 diabetes mellitus	0.000122	0.00123	CbGeAlD
Sunitinib—FLT1—kidney—type 2 diabetes mellitus	0.000122	0.00123	CbGeAlD
Sunitinib—MAP4K2—liver—type 2 diabetes mellitus	0.000122	0.00123	CbGeAlD
Sunitinib—FLT1—pancreas—type 2 diabetes mellitus	0.000121	0.00122	CbGeAlD
Sunitinib—STK3—liver—type 2 diabetes mellitus	0.00012	0.00121	CbGeAlD
Sunitinib—SLK—adipose tissue—type 2 diabetes mellitus	0.00012	0.00121	CbGeAlD
Sunitinib—FLT1—cortex of kidney—type 2 diabetes mellitus	0.000119	0.0012	CbGeAlD
Sunitinib—FGFR2—adipose tissue—type 2 diabetes mellitus	0.000119	0.0012	CbGeAlD
Sunitinib—ROCK1—liver—type 2 diabetes mellitus	0.000119	0.00119	CbGeAlD
Sunitinib—STK10—cardiovascular system—type 2 diabetes mellitus	0.000118	0.00119	CbGeAlD
Sunitinib—JAK2—adipose tissue—type 2 diabetes mellitus	0.000118	0.00119	CbGeAlD
Sunitinib—TAOK3—cardiovascular system—type 2 diabetes mellitus	0.000118	0.00119	CbGeAlD
Sunitinib—EPHB6—cortex of kidney—type 2 diabetes mellitus	0.000118	0.00118	CbGeAlD
Sunitinib—KDR—nephron tubule—type 2 diabetes mellitus	0.000117	0.00118	CbGeAlD
Sunitinib—PDGFRA—cardiovascular system—type 2 diabetes mellitus	0.000117	0.00118	CbGeAlD
Sunitinib—YES1—kidney—type 2 diabetes mellitus	0.000117	0.00118	CbGeAlD
Sunitinib—FYN—adipose tissue—type 2 diabetes mellitus	0.000116	0.00117	CbGeAlD
Sunitinib—YES1—pancreas—type 2 diabetes mellitus	0.000116	0.00117	CbGeAlD
Sunitinib—DYRK1A—liver—type 2 diabetes mellitus	0.000116	0.00117	CbGeAlD
Sunitinib—STK10—kidney—type 2 diabetes mellitus	0.000116	0.00116	CbGeAlD
Sunitinib—TAOK3—kidney—type 2 diabetes mellitus	0.000115	0.00116	CbGeAlD
Sunitinib—TAOK3—pancreas—type 2 diabetes mellitus	0.000114	0.00115	CbGeAlD
Sunitinib—MAP3K3—adipose tissue—type 2 diabetes mellitus	0.000114	0.00115	CbGeAlD
Sunitinib—MAP4K5—adipose tissue—type 2 diabetes mellitus	0.000114	0.00115	CbGeAlD
Sunitinib—YES1—cortex of kidney—type 2 diabetes mellitus	0.000114	0.00114	CbGeAlD
Sunitinib—MERTK—liver—type 2 diabetes mellitus	0.000113	0.00114	CbGeAlD
Sunitinib—TAOK3—cortex of kidney—type 2 diabetes mellitus	0.000112	0.00113	CbGeAlD
Sunitinib—MAP4K4—liver—type 2 diabetes mellitus	0.000111	0.00112	CbGeAlD
Sunitinib—NUAK2—liver—type 2 diabetes mellitus	0.00011	0.00111	CbGeAlD
Sunitinib—FLT1—adipose tissue—type 2 diabetes mellitus	0.00011	0.00111	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.00011	0.00111	CbGeAlD
Sunitinib—MAP3K12—liver—type 2 diabetes mellitus	0.000109	0.0011	CbGeAlD
Sunitinib—FLT3—liver—type 2 diabetes mellitus	0.000109	0.0011	CbGeAlD
Sunitinib—EPHB6—adipose tissue—type 2 diabetes mellitus	0.000109	0.0011	CbGeAlD
Sunitinib—RPS6KA3—liver—type 2 diabetes mellitus	0.000108	0.00109	CbGeAlD
Sunitinib—MAP2K1—liver—type 2 diabetes mellitus	0.000107	0.00108	CbGeAlD
Sunitinib—CSNK1A1—liver—type 2 diabetes mellitus	0.000106	0.00106	CbGeAlD
Sunitinib—MAP2K5—cardiovascular system—type 2 diabetes mellitus	0.000105	0.00106	CbGeAlD
Sunitinib—KDR—cardiovascular system—type 2 diabetes mellitus	0.000105	0.00106	CbGeAlD
Sunitinib—YES1—adipose tissue—type 2 diabetes mellitus	0.000105	0.00106	CbGeAlD
Sunitinib—CLK1—liver—type 2 diabetes mellitus	0.000105	0.00106	CbGeAlD
Sunitinib—STK10—adipose tissue—type 2 diabetes mellitus	0.000104	0.00105	CbGeAlD
Sunitinib—KIT—nephron tubule—type 2 diabetes mellitus	0.000104	0.00105	CbGeAlD
Sunitinib—TAOK3—adipose tissue—type 2 diabetes mellitus	0.000104	0.00105	CbGeAlD
Sunitinib—KDR—kidney—type 2 diabetes mellitus	0.000103	0.00104	CbGeAlD
Sunitinib—PDGFRA—adipose tissue—type 2 diabetes mellitus	0.000103	0.00104	CbGeAlD
Sunitinib—CAMK2G—liver—type 2 diabetes mellitus	0.000103	0.00104	CbGeAlD
Sunitinib—BMP2K—liver—type 2 diabetes mellitus	0.000103	0.00104	CbGeAlD
Sunitinib—CSF1R—cardiovascular system—type 2 diabetes mellitus	0.000103	0.00104	CbGeAlD
Sunitinib—LRRK2—liver—type 2 diabetes mellitus	0.000102	0.00103	CbGeAlD
Sunitinib—PRKAA1—liver—type 2 diabetes mellitus	0.000101	0.00101	CbGeAlD
Sunitinib—KDR—cortex of kidney—type 2 diabetes mellitus	0.000101	0.00101	CbGeAlD
Sunitinib—MAP2K5—cortex of kidney—type 2 diabetes mellitus	0.000101	0.00101	CbGeAlD
Sunitinib—PTK2B—liver—type 2 diabetes mellitus	9.95e-05	0.001	CbGeAlD
Sunitinib—FLT4—liver—type 2 diabetes mellitus	9.92e-05	0.001	CbGeAlD
Sunitinib—CSNK1E—liver—type 2 diabetes mellitus	9.79e-05	0.000987	CbGeAlD
Sunitinib—FGFR1—liver—type 2 diabetes mellitus	9.79e-05	0.000987	CbGeAlD
Sunitinib—IRAK4—liver—type 2 diabetes mellitus	9.64e-05	0.000971	CbGeAlD
Sunitinib—MAP2K2—liver—type 2 diabetes mellitus	9.42e-05	0.00095	CbGeAlD
Sunitinib—ULK3—liver—type 2 diabetes mellitus	9.42e-05	0.00095	CbGeAlD
Sunitinib—MAP3K2—liver—type 2 diabetes mellitus	9.36e-05	0.000943	CbGeAlD
Sunitinib—KIT—cardiovascular system—type 2 diabetes mellitus	9.35e-05	0.000942	CbGeAlD
Sunitinib—KDR—adipose tissue—type 2 diabetes mellitus	9.3e-05	0.000937	CbGeAlD
Sunitinib—MAP2K5—adipose tissue—type 2 diabetes mellitus	9.3e-05	0.000937	CbGeAlD
Sunitinib—MAP3K7—liver—type 2 diabetes mellitus	9.27e-05	0.000934	CbGeAlD
Sunitinib—TBK1—liver—type 2 diabetes mellitus	9.16e-05	0.000924	CbGeAlD
Sunitinib—KIT—kidney—type 2 diabetes mellitus	9.14e-05	0.000922	CbGeAlD
Sunitinib—PDGFRB—cardiovascular system—type 2 diabetes mellitus	9.13e-05	0.00092	CbGeAlD
Sunitinib—TYK2—liver—type 2 diabetes mellitus	9.1e-05	0.000917	CbGeAlD
Sunitinib—KIT—pancreas—type 2 diabetes mellitus	9.08e-05	0.000916	CbGeAlD
Sunitinib—CSF1R—adipose tissue—type 2 diabetes mellitus	9.08e-05	0.000915	CbGeAlD
Sunitinib—IRAK1—liver—type 2 diabetes mellitus	8.98e-05	0.000905	CbGeAlD
Sunitinib—PDGFRB—kidney—type 2 diabetes mellitus	8.93e-05	0.0009	CbGeAlD
Sunitinib—KIT—cortex of kidney—type 2 diabetes mellitus	8.91e-05	0.000898	CbGeAlD
Sunitinib—PDGFRB—pancreas—type 2 diabetes mellitus	8.87e-05	0.000894	CbGeAlD
Sunitinib—RPS6KB1—liver—type 2 diabetes mellitus	8.81e-05	0.000888	CbGeAlD
Sunitinib—FGR—liver—type 2 diabetes mellitus	8.76e-05	0.000883	CbGeAlD
Sunitinib—AXL—liver—type 2 diabetes mellitus	8.73e-05	0.000879	CbGeAlD
Sunitinib—PDGFRB—cortex of kidney—type 2 diabetes mellitus	8.7e-05	0.000877	CbGeAlD
Sunitinib—SLK—liver—type 2 diabetes mellitus	8.4e-05	0.000847	CbGeAlD
Sunitinib—CYP3A7—liver—type 2 diabetes mellitus	8.37e-05	0.000844	CbGeAlD
Sunitinib—FGFR2—liver—type 2 diabetes mellitus	8.32e-05	0.000839	CbGeAlD
Sunitinib—JAK2—liver—type 2 diabetes mellitus	8.28e-05	0.000835	CbGeAlD
Sunitinib—KIT—adipose tissue—type 2 diabetes mellitus	8.24e-05	0.000831	CbGeAlD
Sunitinib—FYN—liver—type 2 diabetes mellitus	8.17e-05	0.000823	CbGeAlD
Sunitinib—ABCC4—nephron tubule—type 2 diabetes mellitus	8.09e-05	0.000816	CbGeAlD
Sunitinib—PDGFRB—adipose tissue—type 2 diabetes mellitus	8.05e-05	0.000811	CbGeAlD
Sunitinib—MAP4K5—liver—type 2 diabetes mellitus	7.98e-05	0.000804	CbGeAlD
Sunitinib—MAP3K3—liver—type 2 diabetes mellitus	7.98e-05	0.000804	CbGeAlD
Sunitinib—KCNH2—islet of Langerhans—type 2 diabetes mellitus	7.98e-05	0.000804	CbGeAlD
Sunitinib—ABCC2—nephron tubule—type 2 diabetes mellitus	7.83e-05	0.00079	CbGeAlD
Sunitinib—FLT1—liver—type 2 diabetes mellitus	7.72e-05	0.000778	CbGeAlD
Sunitinib—YES1—liver—type 2 diabetes mellitus	7.37e-05	0.000743	CbGeAlD
Sunitinib—STK10—liver—type 2 diabetes mellitus	7.3e-05	0.000736	CbGeAlD
Sunitinib—TAOK3—liver—type 2 diabetes mellitus	7.28e-05	0.000733	CbGeAlD
Sunitinib—PDGFRA—liver—type 2 diabetes mellitus	7.23e-05	0.000729	CbGeAlD
Sunitinib—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	7.12e-05	0.000717	CbGeAlD
Sunitinib—ABCC4—kidney—type 2 diabetes mellitus	7.11e-05	0.000717	CbGeAlD
Sunitinib—ABCC4—pancreas—type 2 diabetes mellitus	7.06e-05	0.000712	CbGeAlD
Sunitinib—ABCC4—cortex of kidney—type 2 diabetes mellitus	6.93e-05	0.000698	CbGeAlD
Sunitinib—ABCC2—kidney—type 2 diabetes mellitus	6.88e-05	0.000694	CbGeAlD
Sunitinib—ABCC2—cortex of kidney—type 2 diabetes mellitus	6.7e-05	0.000676	CbGeAlD
Sunitinib—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	6.59e-05	0.000664	CbGeAlD
Sunitinib—MAP2K5—liver—type 2 diabetes mellitus	6.52e-05	0.000657	CbGeAlD
Sunitinib—KDR—liver—type 2 diabetes mellitus	6.52e-05	0.000657	CbGeAlD
Sunitinib—ABCC4—adipose tissue—type 2 diabetes mellitus	6.41e-05	0.000646	CbGeAlD
Sunitinib—CSF1R—liver—type 2 diabetes mellitus	6.37e-05	0.000642	CbGeAlD
Sunitinib—Nervous system disorder—Orlistat—type 2 diabetes mellitus	5.98e-05	0.00044	CcSEcCtD
Sunitinib—Dizziness—Sitagliptin—type 2 diabetes mellitus	5.97e-05	0.00044	CcSEcCtD
Sunitinib—Hypertension—Metformin—type 2 diabetes mellitus	5.94e-05	0.000437	CcSEcCtD
Sunitinib—Angioedema—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000437	CcSEcCtD
Sunitinib—Oedema peripheral—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000437	CcSEcCtD
Sunitinib—Skin disorder—Orlistat—type 2 diabetes mellitus	5.92e-05	0.000436	CcSEcCtD
Sunitinib—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	5.91e-05	0.000435	CcSEcCtD
Sunitinib—Back pain—Losartan—type 2 diabetes mellitus	5.91e-05	0.000435	CcSEcCtD
Sunitinib—Abdominal pain—Glyburide—type 2 diabetes mellitus	5.91e-05	0.000435	CcSEcCtD
Sunitinib—Dyspepsia—Gliclazide—type 2 diabetes mellitus	5.91e-05	0.000435	CcSEcCtD
Sunitinib—Anorexia—Valsartan—type 2 diabetes mellitus	5.88e-05	0.000433	CcSEcCtD
Sunitinib—Muscle spasms—Losartan—type 2 diabetes mellitus	5.87e-05	0.000433	CcSEcCtD
Sunitinib—Asthenia—Bromocriptine—type 2 diabetes mellitus	5.87e-05	0.000432	CcSEcCtD
Sunitinib—Myalgia—Metformin—type 2 diabetes mellitus	5.86e-05	0.000431	CcSEcCtD
Sunitinib—Chest pain—Metformin—type 2 diabetes mellitus	5.86e-05	0.000431	CcSEcCtD
Sunitinib—Headache—Pioglitazone—type 2 diabetes mellitus	5.83e-05	0.000429	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	5.82e-05	0.000428	CcSEcCtD
Sunitinib—Leukopenia—Irbesartan—type 2 diabetes mellitus	5.81e-05	0.000428	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	5.79e-05	0.000427	CcSEcCtD
Sunitinib—Fatigue—Gliclazide—type 2 diabetes mellitus	5.79e-05	0.000426	CcSEcCtD
Sunitinib—KIT—liver—type 2 diabetes mellitus	5.78e-05	0.000583	CbGeAlD
Sunitinib—Nausea—Glipizide—type 2 diabetes mellitus	5.77e-05	0.000425	CcSEcCtD
Sunitinib—KCNH2—cardiovascular system—type 2 diabetes mellitus	5.77e-05	0.000581	CbGeAlD
Sunitinib—Vomiting—Glimepiride—type 2 diabetes mellitus	5.76e-05	0.000424	CcSEcCtD
Sunitinib—Vomiting—Sitagliptin—type 2 diabetes mellitus	5.74e-05	0.000423	CcSEcCtD
Sunitinib—Pain—Gliclazide—type 2 diabetes mellitus	5.74e-05	0.000423	CcSEcCtD
Sunitinib—Constipation—Gliclazide—type 2 diabetes mellitus	5.74e-05	0.000423	CcSEcCtD
Sunitinib—Rash—Glimepiride—type 2 diabetes mellitus	5.71e-05	0.000421	CcSEcCtD
Sunitinib—ABCG2—nephron tubule—type 2 diabetes mellitus	5.71e-05	0.000576	CbGeAlD
Sunitinib—Dermatitis—Glimepiride—type 2 diabetes mellitus	5.71e-05	0.00042	CcSEcCtD
Sunitinib—Rash—Sitagliptin—type 2 diabetes mellitus	5.7e-05	0.000419	CcSEcCtD
Sunitinib—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.69e-05	0.000419	CcSEcCtD
Sunitinib—Erythema multiforme—Ramipril—type 2 diabetes mellitus	5.69e-05	0.000419	CcSEcCtD
Sunitinib—Headache—Glimepiride—type 2 diabetes mellitus	5.68e-05	0.000418	CcSEcCtD
Sunitinib—Cough—Irbesartan—type 2 diabetes mellitus	5.67e-05	0.000417	CcSEcCtD
Sunitinib—Headache—Sitagliptin—type 2 diabetes mellitus	5.66e-05	0.000417	CcSEcCtD
Sunitinib—Anaemia—Losartan—type 2 diabetes mellitus	5.65e-05	0.000416	CcSEcCtD
Sunitinib—PDGFRB—liver—type 2 diabetes mellitus	5.65e-05	0.000569	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.62e-05	0.000414	CcSEcCtD
Sunitinib—Oedema—Metformin—type 2 diabetes mellitus	5.62e-05	0.000413	CcSEcCtD
Sunitinib—Hypertension—Irbesartan—type 2 diabetes mellitus	5.61e-05	0.000413	CcSEcCtD
Sunitinib—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.59e-05	0.000412	CcSEcCtD
Sunitinib—Flushing—Ramipril—type 2 diabetes mellitus	5.59e-05	0.000411	CcSEcCtD
Sunitinib—Angioedema—Losartan—type 2 diabetes mellitus	5.58e-05	0.000411	CcSEcCtD
Sunitinib—Infection—Metformin—type 2 diabetes mellitus	5.58e-05	0.000411	CcSEcCtD
Sunitinib—Insomnia—Valsartan—type 2 diabetes mellitus	5.58e-05	0.000411	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.55e-05	0.000409	CcSEcCtD
Sunitinib—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.54e-05	0.000408	CcSEcCtD
Sunitinib—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.53e-05	0.000407	CcSEcCtD
Sunitinib—Chest pain—Irbesartan—type 2 diabetes mellitus	5.53e-05	0.000407	CcSEcCtD
Sunitinib—Myalgia—Irbesartan—type 2 diabetes mellitus	5.53e-05	0.000407	CcSEcCtD
Sunitinib—Shock—Metformin—type 2 diabetes mellitus	5.52e-05	0.000407	CcSEcCtD
Sunitinib—Insomnia—Orlistat—type 2 diabetes mellitus	5.51e-05	0.000406	CcSEcCtD
Sunitinib—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.51e-05	0.000405	CcSEcCtD
Sunitinib—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.51e-05	0.000405	CcSEcCtD
Sunitinib—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.5e-05	0.000405	CcSEcCtD
Sunitinib—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.5e-05	0.000405	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000404	CcSEcCtD
Sunitinib—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.49e-05	0.000404	CcSEcCtD
Sunitinib—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.47e-05	0.000403	CcSEcCtD
Sunitinib—Leukopenia—Losartan—type 2 diabetes mellitus	5.47e-05	0.000403	CcSEcCtD
Sunitinib—Skin disorder—Metformin—type 2 diabetes mellitus	5.45e-05	0.000402	CcSEcCtD
Sunitinib—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.44e-05	0.0004	CcSEcCtD
Sunitinib—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.43e-05	0.0004	CcSEcCtD
Sunitinib—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000399	CcSEcCtD
Sunitinib—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.41e-05	0.000398	CcSEcCtD
Sunitinib—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.41e-05	0.000398	CcSEcCtD
Sunitinib—Nausea—Glimepiride—type 2 diabetes mellitus	5.38e-05	0.000396	CcSEcCtD
Sunitinib—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000396	CcSEcCtD
Sunitinib—Nausea—Sitagliptin—type 2 diabetes mellitus	5.37e-05	0.000395	CcSEcCtD
Sunitinib—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.36e-05	0.000395	CcSEcCtD
Sunitinib—Asthenia—Glyburide—type 2 diabetes mellitus	5.36e-05	0.000395	CcSEcCtD
Sunitinib—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.36e-05	0.000395	CcSEcCtD
Sunitinib—Anorexia—Metformin—type 2 diabetes mellitus	5.35e-05	0.000394	CcSEcCtD
Sunitinib—Cough—Losartan—type 2 diabetes mellitus	5.33e-05	0.000393	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.32e-05	0.000392	CcSEcCtD
Sunitinib—Alopecia—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000392	CcSEcCtD
Sunitinib—Fatigue—Valsartan—type 2 diabetes mellitus	5.32e-05	0.000391	CcSEcCtD
Sunitinib—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.31e-05	0.000391	CcSEcCtD
Sunitinib—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.31e-05	0.000391	CcSEcCtD
Sunitinib—CYP3A5—nephron tubule—type 2 diabetes mellitus	5.3e-05	0.000534	CbGeAlD
Sunitinib—Oedema—Irbesartan—type 2 diabetes mellitus	5.3e-05	0.00039	CcSEcCtD
Sunitinib—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.3e-05	0.00039	CcSEcCtD
Sunitinib—Pruritus—Glyburide—type 2 diabetes mellitus	5.29e-05	0.000389	CcSEcCtD
Sunitinib—Mental disorder—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000388	CcSEcCtD
Sunitinib—Constipation—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000388	CcSEcCtD
Sunitinib—Infection—Irbesartan—type 2 diabetes mellitus	5.26e-05	0.000388	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.26e-05	0.000387	CcSEcCtD
Sunitinib—Fatigue—Orlistat—type 2 diabetes mellitus	5.25e-05	0.000387	CcSEcCtD
Sunitinib—Malnutrition—Ramipril—type 2 diabetes mellitus	5.24e-05	0.000386	CcSEcCtD
Sunitinib—Erythema—Ramipril—type 2 diabetes mellitus	5.24e-05	0.000386	CcSEcCtD
Sunitinib—Shock—Irbesartan—type 2 diabetes mellitus	5.21e-05	0.000384	CcSEcCtD
Sunitinib—Pain—Orlistat—type 2 diabetes mellitus	5.21e-05	0.000384	CcSEcCtD
Sunitinib—Myalgia—Losartan—type 2 diabetes mellitus	5.2e-05	0.000383	CcSEcCtD
Sunitinib—Chest pain—Losartan—type 2 diabetes mellitus	5.2e-05	0.000383	CcSEcCtD
Sunitinib—Arthralgia—Losartan—type 2 diabetes mellitus	5.2e-05	0.000383	CcSEcCtD
Sunitinib—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.2e-05	0.000383	CcSEcCtD
Sunitinib—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.2e-05	0.000383	CcSEcCtD
Sunitinib—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000382	CcSEcCtD
Sunitinib—Rash—Bromocriptine—type 2 diabetes mellitus	5.15e-05	0.00038	CcSEcCtD
Sunitinib—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.15e-05	0.000379	CcSEcCtD
Sunitinib—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.15e-05	0.000379	CcSEcCtD
Sunitinib—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000378	CcSEcCtD
Sunitinib—Headache—Bromocriptine—type 2 diabetes mellitus	5.12e-05	0.000377	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.12e-05	0.000377	CcSEcCtD
Sunitinib—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.11e-05	0.000377	CcSEcCtD
Sunitinib—Dry mouth—Losartan—type 2 diabetes mellitus	5.09e-05	0.000375	CcSEcCtD
Sunitinib—Anorexia—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.000372	CcSEcCtD
Sunitinib—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.04e-05	0.000371	CcSEcCtD
Sunitinib—Paraesthesia—Metformin—type 2 diabetes mellitus	5.04e-05	0.000371	CcSEcCtD
Sunitinib—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000371	CcSEcCtD
Sunitinib—Dyspnoea—Metformin—type 2 diabetes mellitus	5.01e-05	0.000369	CcSEcCtD
Sunitinib—Oedema—Losartan—type 2 diabetes mellitus	4.99e-05	0.000367	CcSEcCtD
Sunitinib—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.98e-05	0.000367	CcSEcCtD
Sunitinib—Infection—Losartan—type 2 diabetes mellitus	4.95e-05	0.000365	CcSEcCtD
Sunitinib—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.94e-05	0.000364	CcSEcCtD
Sunitinib—Dyspepsia—Metformin—type 2 diabetes mellitus	4.94e-05	0.000364	CcSEcCtD
Sunitinib—Shock—Losartan—type 2 diabetes mellitus	4.91e-05	0.000361	CcSEcCtD
Sunitinib—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.89e-05	0.00036	CcSEcCtD
Sunitinib—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.88e-05	0.000359	CcSEcCtD
Sunitinib—Decreased appetite—Metformin—type 2 diabetes mellitus	4.88e-05	0.000359	CcSEcCtD
Sunitinib—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.87e-05	0.000359	CcSEcCtD
Sunitinib—Nausea—Bromocriptine—type 2 diabetes mellitus	4.86e-05	0.000358	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.85e-05	0.000357	CcSEcCtD
Sunitinib—Fatigue—Metformin—type 2 diabetes mellitus	4.84e-05	0.000356	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.83e-05	0.000355	CcSEcCtD
Sunitinib—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000355	CcSEcCtD
Sunitinib—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000355	CcSEcCtD
Sunitinib—Asthenia—Gliclazide—type 2 diabetes mellitus	4.82e-05	0.000355	CcSEcCtD
Sunitinib—Constipation—Metformin—type 2 diabetes mellitus	4.8e-05	0.000354	CcSEcCtD
Sunitinib—Angioedema—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000352	CcSEcCtD
Sunitinib—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.76e-05	0.00035	CcSEcCtD
Sunitinib—Anorexia—Losartan—type 2 diabetes mellitus	4.75e-05	0.00035	CcSEcCtD
Sunitinib—Vomiting—Glyburide—type 2 diabetes mellitus	4.75e-05	0.00035	CcSEcCtD
Sunitinib—Pruritus—Gliclazide—type 2 diabetes mellitus	4.75e-05	0.00035	CcSEcCtD
Sunitinib—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000348	CcSEcCtD
Sunitinib—Rash—Glyburide—type 2 diabetes mellitus	4.71e-05	0.000347	CcSEcCtD
Sunitinib—Dermatitis—Glyburide—type 2 diabetes mellitus	4.71e-05	0.000347	CcSEcCtD
Sunitinib—Leukopenia—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000345	CcSEcCtD
Sunitinib—Headache—Glyburide—type 2 diabetes mellitus	4.68e-05	0.000345	CcSEcCtD
Sunitinib—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000343	CcSEcCtD
Sunitinib—CYP3A5—kidney—type 2 diabetes mellitus	4.66e-05	0.00047	CbGeAlD
Sunitinib—CYP3A5—pancreas—type 2 diabetes mellitus	4.63e-05	0.000467	CbGeAlD
Sunitinib—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.000339	CcSEcCtD
Sunitinib—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.59e-05	0.000338	CcSEcCtD
Sunitinib—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.59e-05	0.000338	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000337	CcSEcCtD
Sunitinib—Cough—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000337	CcSEcCtD
Sunitinib—Fatigue—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000336	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.54e-05	0.000335	CcSEcCtD
Sunitinib—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.54e-05	0.000334	CcSEcCtD
Sunitinib—Convulsion—Ramipril—type 2 diabetes mellitus	4.54e-05	0.000334	CcSEcCtD
Sunitinib—CYP3A5—cortex of kidney—type 2 diabetes mellitus	4.54e-05	0.000457	CbGeAlD
Sunitinib—Constipation—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000334	CcSEcCtD
Sunitinib—Pain—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000334	CcSEcCtD
Sunitinib—ABCG2—adipose tissue—type 2 diabetes mellitus	4.52e-05	0.000456	CbGeAlD
Sunitinib—Insomnia—Losartan—type 2 diabetes mellitus	4.51e-05	0.000332	CcSEcCtD
Sunitinib—ABCC4—liver—type 2 diabetes mellitus	4.5e-05	0.000453	CbGeAlD
Sunitinib—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.49e-05	0.000331	CcSEcCtD
Sunitinib—Paraesthesia—Losartan—type 2 diabetes mellitus	4.48e-05	0.00033	CcSEcCtD
Sunitinib—Chest pain—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000328	CcSEcCtD
Sunitinib—Myalgia—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000328	CcSEcCtD
Sunitinib—Arthralgia—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000328	CcSEcCtD
Sunitinib—Dyspnoea—Losartan—type 2 diabetes mellitus	4.45e-05	0.000327	CcSEcCtD
Sunitinib—Nausea—Glyburide—type 2 diabetes mellitus	4.44e-05	0.000327	CcSEcCtD
Sunitinib—Abdominal pain—Metformin—type 2 diabetes mellitus	4.44e-05	0.000327	CcSEcCtD
Sunitinib—Dizziness—Gliclazide—type 2 diabetes mellitus	4.44e-05	0.000327	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000326	CcSEcCtD
Sunitinib—Asthenia—Valsartan—type 2 diabetes mellitus	4.42e-05	0.000326	CcSEcCtD
Sunitinib—Dyspepsia—Losartan—type 2 diabetes mellitus	4.39e-05	0.000323	CcSEcCtD
Sunitinib—Asthenia—Orlistat—type 2 diabetes mellitus	4.37e-05	0.000322	CcSEcCtD
Sunitinib—Pruritus—Valsartan—type 2 diabetes mellitus	4.36e-05	0.000321	CcSEcCtD
Sunitinib—Dry mouth—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000321	CcSEcCtD
Sunitinib—ABCC2—liver—type 2 diabetes mellitus	4.35e-05	0.000439	CbGeAlD
Sunitinib—Decreased appetite—Losartan—type 2 diabetes mellitus	4.33e-05	0.000319	CcSEcCtD
Sunitinib—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.33e-05	0.000319	CcSEcCtD
Sunitinib—Pruritus—Orlistat—type 2 diabetes mellitus	4.31e-05	0.000317	CcSEcCtD
Sunitinib—Fatigue—Losartan—type 2 diabetes mellitus	4.3e-05	0.000317	CcSEcCtD
Sunitinib—Oedema—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000315	CcSEcCtD
Sunitinib—Vomiting—Gliclazide—type 2 diabetes mellitus	4.27e-05	0.000314	CcSEcCtD
Sunitinib—Constipation—Losartan—type 2 diabetes mellitus	4.26e-05	0.000314	CcSEcCtD
Sunitinib—Pain—Losartan—type 2 diabetes mellitus	4.26e-05	0.000314	CcSEcCtD
Sunitinib—Rash—Gliclazide—type 2 diabetes mellitus	4.23e-05	0.000312	CcSEcCtD
Sunitinib—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.23e-05	0.000311	CcSEcCtD
Sunitinib—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.22e-05	0.000311	CcSEcCtD
Sunitinib—Shock—Ramipril—type 2 diabetes mellitus	4.21e-05	0.00031	CcSEcCtD
Sunitinib—Headache—Gliclazide—type 2 diabetes mellitus	4.2e-05	0.00031	CcSEcCtD
Sunitinib—CYP3A5—adipose tissue—type 2 diabetes mellitus	4.2e-05	0.000423	CbGeAlD
Sunitinib—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000309	CcSEcCtD
Sunitinib—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000308	CcSEcCtD
Sunitinib—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000308	CcSEcCtD
Sunitinib—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000308	CcSEcCtD
Sunitinib—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.17e-05	0.000307	CcSEcCtD
Sunitinib—Skin disorder—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000306	CcSEcCtD
Sunitinib—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.08e-05	0.0003	CcSEcCtD
Sunitinib—Dizziness—Valsartan—type 2 diabetes mellitus	4.08e-05	0.0003	CcSEcCtD
Sunitinib—Anorexia—Ramipril—type 2 diabetes mellitus	4.08e-05	0.0003	CcSEcCtD
Sunitinib—Dizziness—Orlistat—type 2 diabetes mellitus	4.03e-05	0.000297	CcSEcCtD
Sunitinib—Asthenia—Metformin—type 2 diabetes mellitus	4.03e-05	0.000297	CcSEcCtD
Sunitinib—Nausea—Gliclazide—type 2 diabetes mellitus	3.99e-05	0.000294	CcSEcCtD
Sunitinib—Pruritus—Metformin—type 2 diabetes mellitus	3.97e-05	0.000292	CcSEcCtD
Sunitinib—Body temperature increased—Losartan—type 2 diabetes mellitus	3.94e-05	0.00029	CcSEcCtD
Sunitinib—Abdominal pain—Losartan—type 2 diabetes mellitus	3.94e-05	0.00029	CcSEcCtD
Sunitinib—Vomiting—Valsartan—type 2 diabetes mellitus	3.92e-05	0.000289	CcSEcCtD
Sunitinib—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000287	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000287	CcSEcCtD
Sunitinib—Rash—Valsartan—type 2 diabetes mellitus	3.89e-05	0.000286	CcSEcCtD
Sunitinib—Dermatitis—Valsartan—type 2 diabetes mellitus	3.88e-05	0.000286	CcSEcCtD
Sunitinib—Vomiting—Orlistat—type 2 diabetes mellitus	3.87e-05	0.000285	CcSEcCtD
Sunitinib—Insomnia—Ramipril—type 2 diabetes mellitus	3.87e-05	0.000285	CcSEcCtD
Sunitinib—Headache—Valsartan—type 2 diabetes mellitus	3.86e-05	0.000284	CcSEcCtD
Sunitinib—Diarrhoea—Metformin—type 2 diabetes mellitus	3.84e-05	0.000283	CcSEcCtD
Sunitinib—Rash—Orlistat—type 2 diabetes mellitus	3.84e-05	0.000283	CcSEcCtD
Sunitinib—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000283	CcSEcCtD
Sunitinib—Dermatitis—Orlistat—type 2 diabetes mellitus	3.84e-05	0.000283	CcSEcCtD
Sunitinib—Headache—Orlistat—type 2 diabetes mellitus	3.82e-05	0.000281	CcSEcCtD
Sunitinib—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000281	CcSEcCtD
Sunitinib—Asthenia—Irbesartan—type 2 diabetes mellitus	3.8e-05	0.00028	CcSEcCtD
Sunitinib—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000277	CcSEcCtD
Sunitinib—Pruritus—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.000276	CcSEcCtD
Sunitinib—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000274	CcSEcCtD
Sunitinib—Dizziness—Metformin—type 2 diabetes mellitus	3.71e-05	0.000273	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000272	CcSEcCtD
Sunitinib—Fatigue—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000271	CcSEcCtD
Sunitinib—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.67e-05	0.000271	CcSEcCtD
Sunitinib—Nausea—Valsartan—type 2 diabetes mellitus	3.66e-05	0.00027	CcSEcCtD
Sunitinib—Constipation—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000269	CcSEcCtD
Sunitinib—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.63e-05	0.000267	CcSEcCtD
Sunitinib—Nausea—Orlistat—type 2 diabetes mellitus	3.62e-05	0.000266	CcSEcCtD
Sunitinib—Asthenia—Losartan—type 2 diabetes mellitus	3.58e-05	0.000263	CcSEcCtD
Sunitinib—Vomiting—Metformin—type 2 diabetes mellitus	3.57e-05	0.000263	CcSEcCtD
Sunitinib—Rash—Metformin—type 2 diabetes mellitus	3.54e-05	0.000261	CcSEcCtD
Sunitinib—Dermatitis—Metformin—type 2 diabetes mellitus	3.54e-05	0.00026	CcSEcCtD
Sunitinib—Pruritus—Losartan—type 2 diabetes mellitus	3.53e-05	0.00026	CcSEcCtD
Sunitinib—Headache—Metformin—type 2 diabetes mellitus	3.52e-05	0.000259	CcSEcCtD
Sunitinib—Dizziness—Irbesartan—type 2 diabetes mellitus	3.5e-05	0.000258	CcSEcCtD
Sunitinib—ABCB1—islet of Langerhans—type 2 diabetes mellitus	3.5e-05	0.000353	CbGeAlD
Sunitinib—CYP3A4—kidney—type 2 diabetes mellitus	3.5e-05	0.000352	CbGeAlD
Sunitinib—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000257	CcSEcCtD
Sunitinib—Diarrhoea—Losartan—type 2 diabetes mellitus	3.41e-05	0.000251	CcSEcCtD
Sunitinib—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000249	CcSEcCtD
Sunitinib—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000249	CcSEcCtD
Sunitinib—Vomiting—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000248	CcSEcCtD
Sunitinib—Rash—Irbesartan—type 2 diabetes mellitus	3.34e-05	0.000246	CcSEcCtD
Sunitinib—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.34e-05	0.000246	CcSEcCtD
Sunitinib—Nausea—Metformin—type 2 diabetes mellitus	3.34e-05	0.000246	CcSEcCtD
Sunitinib—Headache—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000244	CcSEcCtD
Sunitinib—Dizziness—Losartan—type 2 diabetes mellitus	3.3e-05	0.000243	CcSEcCtD
Sunitinib—ABCG2—liver—type 2 diabetes mellitus	3.17e-05	0.00032	CbGeAlD
Sunitinib—Vomiting—Losartan—type 2 diabetes mellitus	3.17e-05	0.000233	CcSEcCtD
Sunitinib—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.15e-05	0.000232	CcSEcCtD
Sunitinib—Nausea—Irbesartan—type 2 diabetes mellitus	3.15e-05	0.000232	CcSEcCtD
Sunitinib—Rash—Losartan—type 2 diabetes mellitus	3.14e-05	0.000232	CcSEcCtD
Sunitinib—Dermatitis—Losartan—type 2 diabetes mellitus	3.14e-05	0.000231	CcSEcCtD
Sunitinib—Headache—Losartan—type 2 diabetes mellitus	3.12e-05	0.00023	CcSEcCtD
Sunitinib—Asthenia—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000226	CcSEcCtD
Sunitinib—Pruritus—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000223	CcSEcCtD
Sunitinib—ABCB1—retina—type 2 diabetes mellitus	2.99e-05	0.000301	CbGeAlD
Sunitinib—Nausea—Losartan—type 2 diabetes mellitus	2.96e-05	0.000218	CcSEcCtD
Sunitinib—CYP3A5—liver—type 2 diabetes mellitus	2.95e-05	0.000297	CbGeAlD
Sunitinib—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000215	CcSEcCtD
Sunitinib—Dizziness—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000208	CcSEcCtD
Sunitinib—ABCB1—nephron tubule—type 2 diabetes mellitus	2.82e-05	0.000284	CbGeAlD
Sunitinib—Vomiting—Ramipril—type 2 diabetes mellitus	2.72e-05	0.0002	CcSEcCtD
Sunitinib—Rash—Ramipril—type 2 diabetes mellitus	2.7e-05	0.000199	CcSEcCtD
Sunitinib—Dermatitis—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000198	CcSEcCtD
Sunitinib—Headache—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000197	CcSEcCtD
Sunitinib—Nausea—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000187	CcSEcCtD
Sunitinib—ABCB1—cardiovascular system—type 2 diabetes mellitus	2.53e-05	0.000255	CbGeAlD
Sunitinib—ABCB1—kidney—type 2 diabetes mellitus	2.48e-05	0.00025	CbGeAlD
Sunitinib—ABCB1—pancreas—type 2 diabetes mellitus	2.46e-05	0.000248	CbGeAlD
Sunitinib—ABCB1—cortex of kidney—type 2 diabetes mellitus	2.41e-05	0.000243	CbGeAlD
Sunitinib—ABCB1—adipose tissue—type 2 diabetes mellitus	2.23e-05	0.000225	CbGeAlD
Sunitinib—CYP3A4—liver—type 2 diabetes mellitus	2.21e-05	0.000223	CbGeAlD
Sunitinib—ABCB1—liver—type 2 diabetes mellitus	1.56e-05	0.000158	CbGeAlD
Sunitinib—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.81e-07	2.33e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—RELA—type 2 diabetes mellitus	3.8e-07	2.33e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.8e-07	2.33e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TGFB1—type 2 diabetes mellitus	3.8e-07	2.32e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—type 2 diabetes mellitus	3.79e-07	2.32e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—type 2 diabetes mellitus	3.79e-07	2.32e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.78e-07	2.32e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.78e-07	2.32e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.76e-07	2.3e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.75e-07	2.29e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.74e-07	2.29e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—EGFR—type 2 diabetes mellitus	3.74e-07	2.29e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.74e-07	2.29e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.73e-07	2.29e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.73e-07	2.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—EGFR—type 2 diabetes mellitus	3.72e-07	2.28e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—AKT1—type 2 diabetes mellitus	3.71e-07	2.27e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.7e-07	2.27e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.7e-07	2.27e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.7e-07	2.26e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.69e-07	2.26e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.69e-07	2.26e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.69e-07	2.26e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.67e-07	2.25e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.65e-07	2.23e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.65e-07	2.23e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.64e-07	2.23e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SRC—type 2 diabetes mellitus	3.64e-07	2.23e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SRC—type 2 diabetes mellitus	3.64e-07	2.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—type 2 diabetes mellitus	3.63e-07	2.22e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.62e-07	2.22e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.62e-07	2.22e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.62e-07	2.21e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—type 2 diabetes mellitus	3.61e-07	2.21e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.61e-07	2.21e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—AKT1—type 2 diabetes mellitus	3.6e-07	2.21e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—type 2 diabetes mellitus	3.6e-07	2.2e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—type 2 diabetes mellitus	3.59e-07	2.2e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.57e-07	2.18e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	3.57e-07	2.18e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—type 2 diabetes mellitus	3.56e-07	2.18e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.56e-07	2.18e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—AKT1—type 2 diabetes mellitus	3.56e-07	2.18e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—EGFR—type 2 diabetes mellitus	3.56e-07	2.18e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.55e-07	2.17e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.55e-07	2.17e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.54e-07	2.17e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.54e-07	2.17e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.53e-07	2.16e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.52e-07	2.15e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.52e-07	2.15e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—type 2 diabetes mellitus	3.5e-07	2.14e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—AKT1—type 2 diabetes mellitus	3.5e-07	2.14e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—AKT1—type 2 diabetes mellitus	3.5e-07	2.14e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.49e-07	2.14e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.48e-07	2.13e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.48e-07	2.13e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.45e-07	2.11e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.45e-07	2.11e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.45e-07	2.11e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SRC—type 2 diabetes mellitus	3.44e-07	2.11e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.43e-07	2.1e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.42e-07	2.09e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.41e-07	2.09e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.41e-07	2.09e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.41e-07	2.09e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.39e-07	2.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.39e-07	2.07e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.39e-07	2.07e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.39e-07	2.07e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.39e-07	2.07e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.37e-07	2.06e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.37e-07	2.06e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.36e-07	2.06e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.36e-07	2.06e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.36e-07	2.05e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.35e-07	2.05e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.35e-07	2.05e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.34e-07	2.05e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.34e-07	2.05e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.33e-07	2.04e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—AKT1—type 2 diabetes mellitus	3.33e-07	2.04e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—type 2 diabetes mellitus	3.32e-07	2.03e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—AKT1—type 2 diabetes mellitus	3.32e-07	2.03e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—type 2 diabetes mellitus	3.31e-07	2.03e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—type 2 diabetes mellitus	3.31e-07	2.03e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.31e-07	2.03e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—AKT1—type 2 diabetes mellitus	3.31e-07	2.03e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.31e-07	2.02e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.29e-07	2.01e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.29e-07	2.01e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—AKT1—type 2 diabetes mellitus	3.29e-07	2.01e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.29e-07	2.01e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.28e-07	2e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.27e-07	2e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.26e-07	2e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.25e-07	1.99e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.25e-07	1.99e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.25e-07	1.99e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.25e-07	1.99e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.24e-07	1.98e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—type 2 diabetes mellitus	3.24e-07	1.98e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.24e-07	1.98e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.24e-07	1.98e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—type 2 diabetes mellitus	3.23e-07	1.98e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—AKT1—type 2 diabetes mellitus	3.23e-07	1.98e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.23e-07	1.97e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.22e-07	1.97e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.21e-07	1.96e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.19e-07	1.95e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.19e-07	1.95e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.19e-07	1.95e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.19e-07	1.95e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.19e-07	1.95e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.18e-07	1.95e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—type 2 diabetes mellitus	3.16e-07	1.93e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.15e-07	1.93e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.13e-07	1.91e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—type 2 diabetes mellitus	3.12e-07	1.91e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.11e-07	1.9e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SRC—type 2 diabetes mellitus	3.1e-07	1.9e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—type 2 diabetes mellitus	3.1e-07	1.9e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.1e-07	1.89e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.09e-07	1.89e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.09e-07	1.89e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.08e-07	1.89e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.08e-07	1.88e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—AKT1—type 2 diabetes mellitus	3.06e-07	1.87e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—type 2 diabetes mellitus	3.06e-07	1.87e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—AKT1—type 2 diabetes mellitus	3.06e-07	1.87e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—AKT1—type 2 diabetes mellitus	3.06e-07	1.87e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.05e-07	1.87e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.04e-07	1.86e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.04e-07	1.86e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.04e-07	1.86e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.03e-07	1.85e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.02e-07	1.85e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.02e-07	1.85e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.02e-07	1.85e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.99e-07	1.83e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.99e-07	1.83e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SRC—type 2 diabetes mellitus	2.99e-07	1.83e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.99e-07	1.83e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—type 2 diabetes mellitus	2.98e-07	1.83e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.98e-07	1.83e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—AKT1—type 2 diabetes mellitus	2.98e-07	1.82e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.97e-07	1.82e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.97e-07	1.81e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—type 2 diabetes mellitus	2.96e-07	1.81e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.96e-07	1.81e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.92e-07	1.79e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.92e-07	1.78e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.91e-07	1.78e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.9e-07	1.77e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.89e-07	1.77e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—type 2 diabetes mellitus	2.88e-07	1.76e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—AKT1—type 2 diabetes mellitus	2.87e-07	1.76e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.87e-07	1.76e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—type 2 diabetes mellitus	2.86e-07	1.75e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—AKT1—type 2 diabetes mellitus	2.86e-07	1.75e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.84e-07	1.74e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.84e-07	1.74e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.82e-07	1.73e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—AKT1—type 2 diabetes mellitus	2.82e-07	1.73e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.81e-07	1.72e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.79e-07	1.71e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.79e-07	1.71e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.79e-07	1.7e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.78e-07	1.7e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.78e-07	1.7e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.77e-07	1.7e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.77e-07	1.69e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—AKT1—type 2 diabetes mellitus	2.75e-07	1.68e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.75e-07	1.68e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.75e-07	1.68e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.74e-07	1.68e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—type 2 diabetes mellitus	2.73e-07	1.67e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—AKT1—type 2 diabetes mellitus	2.73e-07	1.67e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.72e-07	1.66e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.67e-07	1.64e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.66e-07	1.63e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—AKT1—type 2 diabetes mellitus	2.65e-07	1.62e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—AKT1—type 2 diabetes mellitus	2.64e-07	1.61e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.64e-07	1.61e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.64e-07	1.61e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.62e-07	1.6e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.61e-07	1.59e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.6e-07	1.59e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.56e-07	1.56e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.54e-07	1.55e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.53e-07	1.55e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.53e-07	1.55e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT1—type 2 diabetes mellitus	2.52e-07	1.54e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.49e-07	1.53e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.49e-07	1.52e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.45e-07	1.5e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—type 2 diabetes mellitus	2.45e-07	1.5e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—type 2 diabetes mellitus	2.45e-07	1.5e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.4e-07	1.47e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.4e-07	1.47e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.33e-07	1.43e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.33e-07	1.42e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—type 2 diabetes mellitus	2.32e-07	1.42e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.3e-07	1.41e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.27e-07	1.39e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.27e-07	1.39e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.26e-07	1.38e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.26e-07	1.38e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.26e-07	1.38e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.23e-07	1.37e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.2e-07	1.35e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.17e-07	1.33e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.15e-07	1.31e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.14e-07	1.31e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.14e-07	1.31e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.11e-07	1.29e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.11e-07	1.29e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.11e-07	1.29e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—type 2 diabetes mellitus	2.09e-07	1.28e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.07e-07	1.27e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.02e-07	1.24e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.02e-07	1.23e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—type 2 diabetes mellitus	2.01e-07	1.23e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—type 2 diabetes mellitus	2e-07	1.23e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.98e-07	1.21e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.97e-07	1.2e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.94e-07	1.19e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.93e-07	1.18e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.93e-07	1.18e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.91e-07	1.17e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.86e-07	1.14e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.86e-07	1.14e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.85e-07	1.13e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.83e-07	1.12e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.79e-07	1.1e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.78e-07	1.09e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.77e-07	1.08e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.77e-07	1.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.74e-07	1.06e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.73e-07	1.06e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.71e-07	1.05e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.51e-07	9.24e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.48e-07	9.06e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.36e-07	8.31e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-07	7.95e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-07	7.95e-07	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.28e-07	7.86e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-07	7.27e-07	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	9.69e-08	5.93e-07	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.97e-08	3.65e-07	CbGpPWpGaD
